Notably, ROS-mediated stabilization of HIF-1α drives angiogenesis and EMT in hypoxic tumors, but recent studies suggest that HIF-1α can also induce antioxidant responses, mitigating ROS and promoting tumor survival. Here, HIF1A is linked to neoplasm.